Tumor lysis syndrome induced by hydroxyurea therapy for leukemic transformation of polycythemia vera [4]

American Journal of Hematology

Volumn 71, Issue 3, 2002, Pages 237-238

  Ellis, Anne K ^a   Lee, David H ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CYTOTOXIC AGENT; HYDROXYUREA;

AGED; BLOOD CHEMISTRY; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; HYPERKALEMIA; LETTER; LEUKEMIA; MALE; MALIGNANT TRANSFORMATION; NONHODGKIN LYMPHOMA; PATIENT MONITORING; PHLEBOTOMY; PHYSICAL EXAMINATION; POLYCYTHEMIA VERA; PRIORITY JOURNAL; TUMOR LYSIS SYNDROME;

AGED; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; HYDROXYUREA; LEUKEMIA; MALE; POLYCYTHEMIA VERA; TUMOR LYSIS SYNDROME;

EID: 0036829054     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10220     Document Type: Letter

References (4)

1. Hande KR, Garrow GC. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. Am J Med 1993;94:133-139.
2. Razis E, Arlin ZA, Ahmed T, Feldman EJ, Puccio C, Cook P, Chan HG, Helson L, Mittelman A. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia. Acta Haematol 1994;91:171-174.
3. Lotfi M, Brandwein JM. Spontaneous acute tumor lysis syndrome in acute myeloid leukemia? A single case report with discussion of the literature. Leuk Lymphoma 1998;29:625-628.
4. Sparano J, Ramirez M, Wiernik PH. Increasing recognition of corticosteroid induced tumor lysis syndrome in non-Hodgkin's lymphoma. Cancer 1990;65: 1072-1073.